Young adults at risk of psychosis show reduced brain connectivity, a deficit that cannabis use appears to worsen, a new study has found. The breakthrough paves the way for psychosis treatments targeting symptoms that current medications miss.
In the first-of-its-kind study, McGill University researchers detected a marked decrease in synaptic density-;the connections between neurons that enable brain communication-;in individuals at risk of psychosis, compared to a healthy control group.
Not every cannabis user will develop psychosis, but for some, the risks are high. Our research helps clarify why. Cannabis appears to disrupt the brain's natural process of refining and pruning synapses, which is essential for healthy brain development."
- Dr. Romina Mizrahi, senior author of the study and professor in McGill's Department of Psychiatry
Hope for new treatments
Using advanced brain scanning technology, the team studied 49 participants aged 16 to 30, including individuals with recent psychotic symptoms and those considered at high risk. The results, published in JAMA Psychiatry, indicate that lower synaptic density is linked to social withdrawal and lack of motivation, symptoms the researchers say are difficult to treat.
"Current medications largely target hallucinations, but they don't address symptoms that make it difficult to manage social relationships, work, or school," said first author Belen Blasco, a PhD student at McGill's Integrated Program in Neuroscience. "By focusing on synaptic density, we may eventually develop therapies that enhance social function and quality of life for those affected."
